Drug Safety Information for AGGRENOX (Aspirin; dipyridamole)

FDA Safety-related Labeling Changes for AGGRENOX (ASPIRIN; DIPYRIDAMOLE) Rx Drug: Safety Information Link

Adverse Drug Reactions for AGGRENOX* (Aspirin; dipyridamole)

These charts and graphs are based on reports received through the FDA Adverse Event Reporting System (FAERS) program (see below).

Top 20 Adverse Effects Associated with AGGRENOX
(reported in FDA Medwatch/FAERS Reports)

  Side Effect # of FDA Reports
1Cerebrovascular accident552
2Headache*408
3Nausea*275
4Transient ischaemic attack245
5Dizziness231
6Vomiting200
7Diarrhoea192
8Asthenia173
9Fall148
10Fatigue142
11Dyspnoea141
12Myocardial infarction115
13Pain in extremity109
14Pain*107
15Hypertension103
16Drug ineffective98
17Anaemia98
18Chest pain92
19Renal failure acute91
20Pneumonia90

* This side effect also appears in "Top 10 Side Effects of AGGRENOX " in the drug's Review Summary based on AskaPatient reviews.

Top 10 Reasons for Taking AGGRENOX
(associated with FDA Medwatch/FAERS Reports)

Reason # of FDA Reports
1Cerebrovascular accident prophylaxis1481
2Product used for unknown indication1314
3Transient ischaemic attack*1023
4Cerebrovascular accident*994
5Prophylaxis358
6Anticoagulant therapy346
7Thrombosis prophylaxis110
8Hypertension55
9Essential hypertension52
10Antiplatelet therapy41

*Also a top-10 reason in AskaPatient Review Summary.


Types of Adverse Events for AGGRENOX

Total Reports Filed with FDA: 15823


Number of FDA Adverse Event Reports by Patient Age for AGGRENOX

Total Reports Filed with FDA: 15823*


* Reports for drugs with the same active ingredients have been aggregated in this analysis: Aspirin; dipyridamole (Aggrenox)

Charts are based on 15823 reports filed with the FDA between 2004 and June 2015.

Adverse Event Reports are submitted to the FDA by pharmaceutical companies (mandatory reporting is required by manufacturers, distributors, or importers), health care providers such as doctors (voluntary reporting), and by patients themselves (voluntary reporting). More Information on FDA MedWatch (FDA Safety Information and Adverse Event Reporting Program)Voluntary reporting takes place under the FDA's MedWatch program, where health care professionals and consumers submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product. An adverse event is any undesirable experience or extreme side effect associated with the use of a medical product. Adverse events include: death, life threatening event, hospitalization, disability or permanent damage, congenital anomaly or birth defect, medical product use requiring a surgical or other intervention, or other serious medical situation believed to be caused by the drug.

Click to go back to search results and AGGRENOX Reviews and Review Summary .

Historical Analytics of FDA Adverse Event Reports Provided by Druginformer.com. FDA Drug Safety Information, including safety-related labeling updates, required post-approval safety studies, risk evaluation management strategies (REMS), alerts, and recalls are compiled by AskaPatient.com from the U.S. Food and Drug Administration.